BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31375156)

  • 21. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
    Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
    Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical expression of caveolin-1 in normal and neoplastic canine mammary tissue.
    Amorim I; Lopes CC; Faustino AM; Pereira PD
    J Comp Pathol; 2010 Jul; 143(1):39-44. PubMed ID: 20153867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours.
    Yang WY; Liu CH; Chang CJ; Lee CC; Chang KJ; Lin CT
    J Comp Pathol; 2006 Jan; 134(1):70-9. PubMed ID: 16423573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preliminary report on the expression of leptin and leptin receptor (ObR) in normal, hyperplastic and neoplastic canine mammary tissues.
    Ressel L; Finotello R; Innocenti VM; Vannozzi I; Poli A
    Res Vet Sci; 2012 Aug; 93(1):343-9. PubMed ID: 21875727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical study of the expression of E-cadherin in canine mammary tumours.
    Reis AL; Carvalheira J; Schmitt FC; Gärtner F
    Vet Rec; 2003 May; 152(20):621-4. PubMed ID: 12790166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of potential canine mammary tumour cell biomarkers using proteomic approach: Differences in protein profiles among tumour and normal mammary epithelial cells by two-dimensional electrophoresis-based mass spectrometry.
    Fhaikrue I; Srisawat W; Nambooppha B; Pringproa K; Thongtharb A; Prachasilchai W; Sthitmatee N
    Vet Comp Oncol; 2020 Dec; 18(4):787-795. PubMed ID: 32421920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical study of IGF-I and IGF-II expression in canine mammary tumours: Prognostic and diagnostic role.
    Ozmen O
    Acta Vet Hung; 2020 Sep; 68(3):269-274. PubMed ID: 33221734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen receptors in canine mammary gland tumours.
    Sobczak-Filipiak M; Malicka E
    Pol J Vet Sci; 2002; 5(1):1-5. PubMed ID: 11944580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and significance of PTEN in canine mammary gland tumours.
    Qiu C; Lin D; Wang J; Wang L
    Res Vet Sci; 2008 Oct; 85(2):383-8. PubMed ID: 18082231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myoepithelial cell layer integrity in canine mammary carcinoma.
    Sánchez-Céspedes R; Millán Y; Guil-Luna S; García-Monterde J; Reymundo C; Espinosa de los Monteros A; Martín de las Mulas J
    J Comp Pathol; 2011 Jul; 145(1):25-30. PubMed ID: 21247585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of immunohistochemical markers and histological classification in malignant canine mammary tumours.
    Pastor N; Ezquerra LJ; Santella M; Caballé NC; Tarazona R; Durán ME
    Vet Comp Oncol; 2020 Dec; 18(4):753-762. PubMed ID: 32336005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical detection of progesterone and cellular proliferation in canine mammary tumours.
    Thuróczy J; Reisvaag GJ; Perge E; Tibold A; Szilágyi J; Balogh L
    J Comp Pathol; 2007; 137(2-3):122-9. PubMed ID: 17645888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and the molecular forms of neutrophil gelatinase-associated lipocalin and matrix metalloproteinase 9 in canine mammary tumours.
    Chen YC; Chang SC; Huang YH; Lee YJ; Chang CC; Liao JW; Hsu WL
    Vet Comp Oncol; 2019 Sep; 17(3):427-438. PubMed ID: 31050171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of endothelin-1 and endothelin-1 receptor A in canine mammary tumours.
    Restucci B; Martano M; Maiolino P
    Res Vet Sci; 2015 Jun; 100():182-8. PubMed ID: 25816929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Value of Occult Isolated Tumour Cells within Regional Lymph Nodes of Dogs with Malignant Mammary Tumours.
    Coleto AF; Wilson TM; Soares NP; Gundim LF; Castro IP; Guimarães EC; Bandarra MB; Medeiros-Ronchi AA
    J Comp Pathol; 2018 Jan; 158():32-38. PubMed ID: 29422313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of tumour-associated macrophages in canine mammary tumours.
    Raposo T; Gregório H; Pires I; Prada J; Queiroga FL
    Vet Comp Oncol; 2014 Mar; 12(1):10-9. PubMed ID: 22533625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metallothionein expression in canine and feline mammary and melanotic tumours.
    Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
    J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COX-2 over-expression correlates with VEGF and tumour angiogenesis in canine mammary cancer.
    Queiroga FL; Pires I; Parente M; Gregório H; Lopes CS
    Vet J; 2011 Jul; 189(1):77-82. PubMed ID: 20675158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome.
    Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A
    Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of clinicopathological characteristics and oestrogen receptor gene expression in oestrogen receptor-negative, progesterone receptor-positive canine mammary carcinomas.
    Kim NH; Lim HY; Im KS; Shin JI; Kim HW; Sur JH
    J Comp Pathol; 2014 Jul; 151(1):42-50. PubMed ID: 24913515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.